Precision Medicine News and Research

RSS

Benefits of Biomarkers in Colorectal Cancer Treatment

Biomarkers fall into different categories: diagnostic biomarkers, are used to identify a disease; prognostic biomarkers, help clinicians to determine, for example, whether you're more likely to die or have problems with a disease; and there are some that can be used to inform treatment, to determine whether one therapy would be more successful than another.

2 Oct 2017

Proscia’s new product optimized for digital clinical workflows in anatomic pathology labs

Proscia announced today the launch of a new product optimized for digital clinical workflows in anatomic pathology labs. This new platform is set to transform the clinical use of digital pathology in commercial and hospital labs

30 Sep 2017

Indiana University, Regenstrief, LifeOmic team up to advance the development of precision medicine

Indiana University, the Regenstrief Institute and Indianapolis-based technology company LifeOmic have announced a first-of-its kind collaboration to advance the development of precision medicine, a personalized approach to disease treatment and prevention.

30 Sep 2017

Penn researchers develop predictive model to help lung cancer patients avoid ED visits

A pilot program that uses big data to predict which lung cancer patients will require a trip to an emergency department successfully anticipated a third of all ED visits over a two-week trial period, and was further able to identify which patients were at high risk and low risk of requiring such care.

27 Sep 2017

Genetic testing can improve safety of common blood thinner, study shows

Warfarin is a blood thinner that is commonly prescribed to patients to prevent life-threatening blood clots. Despite its longtime use, warfarin remains tricky to dose because a person's genetic makeup influences how the drug is processed in the body.

27 Sep 2017

New approaches to treat aggressive NUT midline carcinoma

Precision medicine, which custom-tailors therapies to the needs of individual patients, is becoming more and more important in cancer therapy. Today, molecular-biological diagnostics can precisely identify alterations in tumor cells.

26 Sep 2017

Analytical Science in Precision Medicine

Pittcon is an analytical conference, so naturally my talk will be about analytical chemistry and how analytical chemistry will become increasingly important in delivering healthcare solutions, not only for rich people, but also, hopefully, for poor people across the world.

From Pittcon 19 Sep 2017

Evosep launches new separation technology tailored for clinical omics at HUPO 2017

Evosep aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics. We will make sample preparation and separation for mass spectrometry analysis 100 times more robust and 10 times faster to enable truly large cohort studies and provide the foundation for precision medicine.

From Evosep 19 Sep 2017

Scientists discover markers for progressive multiple sclerosis

Scientists have uncovered two closely related cytokines -- molecules involved in cell communication and movement -- that may explain why some people develop progressive multiple sclerosis (MS), the most severe form of the disease.

18 Sep 2017

Cancer-fighting cells destroy tumors more effectively after being starved for oxygen

Mountain climbers and endurance athletes are not the only ones to benefit from altitude training - that is, learning to perform well under low-oxygen conditions.

18 Sep 2017

EPFL scientists discover metabolic differences between hepatoblastoma subtypes

Hepatoblastoma is a rare pediatric liver cancer, usually diagnosed in the first three years of life. Histological methods are used to distinguish between the different subtypes of hepatoblastoma.

18 Sep 2017

Myriad Genetics presents positive results of new hereditary cancer test at 36th annual conference of NSGC

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that two important studies will be featured in podium presentations at the 36th annual conference of the National Society of Genetic Counselors in Columbus, OH.

18 Sep 2017

BC Platforms introduces new resource that enables integrated analytics of genomic and clinical data

BC Platforms, a world leader in genomic data management and analysis solutions, today announces it has launched BC|RQUEST, a unique resource that enables integrated analytics of genomic and clinical data.

14 Sep 2017

FDA moves to guard against abuse of ‘orphan drug’ program

The Food and Drug Administration is changing the way it approves medicines known as "orphan drugs" after revelations that drugmakers may be abusing a law intended to help patients with rare diseases.

13 Sep 2017

Antibody therapy found effective in subgroup of patients with treatment-resistant COPD

An antibody treatment reduces the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant chronic obstructive pulmonary disease (COPD), according to the results of two large international trials presented today at the European Respiratory Society International Congress in Milan, Italy, and simultaneously published in the New England Journal of Medicine.

12 Sep 2017

Precision Medicine News and Research

Benefits of Biomarkers in Colorectal Cancer Treatment

Proscia’s new product optimized for digital clinical workflows in anatomic pathology labs

Indiana University, Regenstrief, LifeOmic team up to advance the development of precision medicine

Penn researchers develop predictive model to help lung cancer patients avoid ED visits

Genetic testing can improve safety of common blood thinner, study shows

New approaches to treat aggressive NUT midline carcinoma

Analytical Science in Precision Medicine

Evosep launches new separation technology tailored for clinical omics at HUPO 2017

Scientists discover markers for progressive multiple sclerosis

Cancer-fighting cells destroy tumors more effectively after being starved for oxygen

EPFL scientists discover metabolic differences between hepatoblastoma subtypes

Myriad Genetics presents positive results of new hereditary cancer test at 36th annual conference of NSGC

BC Platforms introduces new resource that enables integrated analytics of genomic and clinical data

FDA moves to guard against abuse of ‘orphan drug’ program

Antibody therapy found effective in subgroup of patients with treatment-resistant COPD

Study provides new insights into biologic networks involved in IBD

Prostate Cancer Awareness Month: Myriad Genetics working to educate public about hereditary cancer risk assessment

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Median Technologies to exhibit its imaging solutions and services at ESMO 2017 Congress

Researchers reveal new approach to precisely identify and treat prostate cancer

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News